
renal cell carcinoma, Prostate cancer, Bladder cancer; Genitourinary tumors; Immunotherapy; Liquid biopsy; Microbiome; Prostate cancer; PSMA; Renal cell carcinoma, genitourinary tumors, Liquid biopsy, liquid biopsy, Genitourinary tumors, Bladder cancer, microbiome, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, prostate cancer, Renal cell carcinoma, Oncology, PSMA, bladder cancer, Immunotherapy, Microbiome, RC254-282
renal cell carcinoma, Prostate cancer, Bladder cancer; Genitourinary tumors; Immunotherapy; Liquid biopsy; Microbiome; Prostate cancer; PSMA; Renal cell carcinoma, genitourinary tumors, Liquid biopsy, liquid biopsy, Genitourinary tumors, Bladder cancer, microbiome, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, prostate cancer, Renal cell carcinoma, Oncology, PSMA, bladder cancer, Immunotherapy, Microbiome, RC254-282
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 6 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
